Flurbiprofen 50mg Tablet Franchise in Ahmedabad

Anti-Inflammatory Pain Relief Tablet Supplier in Bangalore

Flurbiprofen Tablet Distributor in Hyderabad

Arthritis Pain Management Tablet Franchise Opportunity in Jaipur

NSAID Pain Relief Tablet Stockist in Mumbai
Flurbiprofen Tablet Export & Manufacturing in Chandigarh

Home/Products /flurbiprofen-50mg-tablet

Fluorise 50 Tablet

Composition : Flurbiprofen (50mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Fluorise 50 Tablet contains Flurbiprofen 50mg, a trusted non-steroidal anti-inflammatory drug widely used for relief from mild to moderate pain, inflammation, and swelling in musculoskeletal and inflammatory conditions. It is commonly prescribed for arthritis, joint pain, postoperative discomfort, and soft tissue injuries.

Flurbiprofen acts by inhibiting prostaglandin synthesis, reducing inflammation and pain at the affected site. The 50mg strength is ideal for patients requiring mild to moderate pain control, providing reliable therapeutic effects with good tolerability when used as directed.

For hospitals, clinics, and pharmaceutical distributors, Fluorise 50 Tablet is a high-demand pain-management medicine, commonly prescribed by orthopedicians, rheumatologists, surgeons, and general practitioners. Its continuous requirement in pain and inflammation management ensures steady market movement and repeated orders.

Adding Fluorise 50 Tablet to your product portfolio strengthens your pain-management and anti-inflammatory segment, offering opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its broad clinical application and consistent prescription pattern make it a commercially valuable product for pharmaceutical distributors.

Read More

About the Product

Fluorise 50 Tablet contains Flurbiprofen 50mg, a trusted non-steroidal anti-inflammatory drug widely used for relief from mild to moderate pain, inflammation, and swelling in musculoskeletal and inflammatory conditions. It is commonly prescribed for arthritis, joint pain, postoperative discomfort, and soft tissue injuries.

Flurbiprofen acts by inhibiting prostaglandin synthesis, reducing inflammation and pain at the affected site. The 50mg strength is ideal for patients requiring mild to moderate pain control, providing reliable therapeutic effects with good tolerability when used as directed.

For hospitals, clinics, and pharmaceutical distributors, Fluorise 50 Tablet is a high-demand pain-management medicine, commonly prescribed by orthopedicians, rheumatologists, surgeons, and general practitioners. Its continuous requirement in pain and inflammation management ensures steady market movement and repeated orders.

Adding Fluorise 50 Tablet to your product portfolio strengthens your pain-management and anti-inflammatory segment, offering opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its broad clinical application and consistent prescription pattern make it a commercially valuable product for pharmaceutical distributors.

Some patients may experience nausea, abdominal discomfort, indigestion, heartburn, or headache. Rarely, gastrointestinal bleeding, kidney impairment, or severe allergic reactions may occur.

Fluorise 50 Tablet is indicated for the management of mild to moderate pain, osteoarthritis, rheumatoid arthritis, musculoskeletal pain, and other inflammatory conditions. It helps alleviate joint pain, stiffness, and inflammation.

Use strictly under medical supervision. Take with food or milk to reduce gastric irritation. Avoid in patients with hypersensitivity to NSAIDs or history of peptic ulcer disease. Follow the prescribed dosage carefully.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation